fbpx

Nyheder

Lundbeckfonden Ventures nyheder

Download press release here: Acacia_Pharma_starts_Phase_II_clinical_trail_f.PDF
The U.S. Food and Drug Administration has granted 510(k) clearance for Asante Solutions' Pearl Insulin Pump. ASANTE_press_release_051711.pdf
DBV demonstrates ability of VIASKIN® to administer allergen via intact skin by targeting dendrictic cells for safe treatment of allergic disease. News_J_Immunol.pdf
Syntaxin enters manufacturing agreement with SynCo Bio Partners B.V. Progresses Acromegaly programme towards clinic. SynCo_Bio_Release_9_5_2011_(2).pdf
Funds to be used to complete two Phase II programmes
Nexstim, a medical device company, raises over EUR 11 million in new equity financing. Helsinki, Finland – January 26, 2011 – Nexstim Oy, a medical device company commercializing noninvasive brain diagnostic and therapy technologies, today announced that it has closed on additional equity financing of approximately EUR 11.4 million. The investment round was led by...
Russell G. Greig Appointed as Chairman of SyntaxinOxford, UK, 6th January 2011: Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announced Dr Russell G. Greig, Ph. D., has been appointed as Chairman with immediate effect. In joining Syntaxin, Dr. Greig brings with him over 30 years experience in the pharmaceutical industry,...
1 59 60 61 62

Lundbeckfonden Ventures

Nyheder

Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
18. januar 2020
Acacia Pharma Group PLC – Issue of Equity on Share Subscription and Licensing agreement With Cosmo Pharmaceuticals
13. januar 2020
Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR206 and Plans to Advance Program with Alliance Partners Everest Medicines and the Department of Defense
13. januar 2020